Showing results (341-350 of 376) with videos related to
Sort By:
Pageof 38
Neurobiology of Disease|December 15, 2000
Neurotoxicity of the putative transmembrane domain of the prion proteinS Haïk, J M Peyrin, L Lins, et al.AJNR. American Journal of Neuroradiology|September 25, 2020
Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous 18F-FDG-PET/MRI for Tumor Delineation in Head and Neck Cancer?N Pyatigorskaya, R De Laroche, G Bera, et al.British Journal of Cancer|September 19, 2007
Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?C Massard, J-J Voigt, A Laplanche, et al.Neuropathology and Applied Neurobiology|October 9, 2002
Expression of excitatory amino acid transporter-2 (EAAT-2) and glutamine synthetase (GS) in brain macrophages and microglia of SIVmac251-infected macaquesF Chrétien, A-V Vallat-Decouvelaere, C Bossuet, et al.Science (New York, N.Y.)|January 17, 1997
Transmission of the BSE agent to mice in the absence of detectable abnormal prion proteinC I Lasmézas, J P Deslys, O Robain, et al.The EMBO Journal|November 2, 2001
The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion proteinS Gauczynski, J M Peyrin, S Haïk, et al.AJNR. American Journal of Neuroradiology|June 1, 1997
Chronic thalamic stimulation with three-dimensional MR stereotactic guidanceD Dormont, P Cornu, B Pidoux, et al.AJNR. American Journal of Neuroradiology|May 1, 2010
Combined diffusion imaging and MR spectroscopy in the diagnosis of human prion diseasesDamien Galanaud, S Haik, M G Linguraru, et al.AJNR. American Journal of Neuroradiology|July 13, 2013
Long-term white matter changes after severe traumatic brain injury: a 5-year prospective cohortJ Dinkel, A Drier, O Khalilzadeh, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 23, 2002
Behavioural disorders, Parkinson's disease and subthalamic stimulationJ L Houeto, V Mesnage, L Mallet, et al.Pageof 38